Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)
Close on Nov 17, 2026Market cap $4.83MP/E –Yield –
Processa Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Processa Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2016 was -38341.3%. For fiscal 2016 it was -38341.3%, against -2957.2% the year before. The highest annual figure on record is -982.0% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | -38341.3% | −35384.1 |
| FY2015 | Dec 31, 2015 | -2957.2% | +1263.5 |
| FY2014 | Dec 31, 2014 | -4220.7% | −3238.7 |
| FY2013 | Dec 31, 2013 | -982.0% | +288.1 |
| FY2012 | Dec 31, 2012 | -1270.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2016 | Mar 31, 2016 | -5619.0% | – |
See a number that looks wrong?